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Echinococcus vogeli infection in a hunter from the rain 
forest of French Guiana was conﬁ  rmed by imaging and mi-
tochondrial DNA sequence analysis. Serologic examination 
showed typical patterns for both alveolar and cystic echi-
nococcosis. Polycystic echinococcis caused by E. vogeli 
may be an emerging parasitic disease in Central and South 
America.
E
chinococcosis is one of the most lethal helminthic 
zoonoses worldwide. The 4 species of the genus Echi-
nococcus are E. granulosus sensu lato, now including 5 
independent species (1,2), which causes cystic echinococ-
cosis (CE); E. multilocularis, which causes alveolar echi-
nococcosis; E. vogeli, which causes polycystic echinococ-
cosis (PE); and E. oligarthrus, which causes the recently 
described unicystic echinococcosis (3–6). Among these 
species, E. oligarthrus and E. vogeli are neotropical species 
localized exclusively in Central and South America (5,6). 
Only 3 cases of E. oligarthrus infection have been reported 
in the literature (1 from Brazil, 1 from Venezuela, and 1 
from Surinam); 168 E. vogeli cases have been reported in 
12 countries in Central and South America. To date, there 
have been no reports of neotropical echinococcosis in Bo-
livia, Paraguay, Guyana, or French Guiana (5,6). E. granu-
losus occurs sympatrically in South America, whereas E. 
multilocularis does not occur there at all (3,5). As both E. 
vogeli and E. oligarthrus have primarily sylvatic life cycles 
and the diagnosis is usually based on histopathologic ex-
amination of resected lesions, the number of human cases 
might be underestimated because of the small number of 
patients who receive surgical treatment (5,6). We report 
a case of human infection from French Guiana caused by 
E. vogeli.
The Study
In April 2006, a 72-year-old man was admitted to a lo-
cal hospital in Cayenne, French Guiana, for abdominal pain 
and a palpable epigastric mass. The patient hunted jaguars 
in the rain forest of French Guiana and owned dogs. He had 
no history of travel outside French Guiana. An exploratory 
laparotomy performed in June 2006 showed a hard, whitish 
liver tumor, deemed unresectable. Histopathologic exami-
nation of a biopsied sample of the tumor showed multilocu-
lar cysts. Albendazole treatment was started immediately 
after surgery. In January 2007, the patient was referred to 
the Department of General, Endocrine, and Digestive Sur-
gery at the Saint-Louis Hospital, Paris, France. Computed 
tomography showed a multilocular hypoattenuating cystic 
mass in the left side of the liver, inﬁ  ltrating the left glis-
sonian pedicle up to the hepatic hilum (Figure 1, Panel A). 
Magnetic resonance imaging showed a well-deﬁ  ned, thin-
walled, multilocular cystic mass (11 × 10 × 12 cm) involv-
ing segments II, III, and IV of the liver (Figure 1, Panel B) 
and multiple intraperitoneal cysts. The cysts appeared mark-
edly hyperintense on T2-weighted images, hypo-intense on 
T1-weighted images, and showed slight enhancement of 
the septa after gadolinium injection. The patient underwent 
a left hepatectomy and resection of intraperitoneal cysts. 
Analysis of the operative specimen showed multiple large 
and small parasite hooks, with mean lengths of 32.7 μm ± 
1.6 μm and 42.7 μm ± 0.7 μm, respectively (Figure 2).
Two serum samples from the patient (one obtained 
in May 2006, the other in December 2006) were analyzed 
by several immunologic techniques; all indicated infec-
tion with Echinococcus spp. Commercial ELISAs using E. 
granulosus antigens (Bordier Afﬁ  nity Products, Lausanne, 
Switzerland, and Biotrin International, Antony, France) 
and the E. multilocularis-speciﬁ  c  Em2plus-ELISA (Bor-
dier Afﬁ   nity Products, Switzerland) were both strongly 
positive. Conﬁ  rmative Western blots (LD Bio Products, 
Lyon, France) showed a shadow at 16–18 kDa, which is 
characteristic for E. granulosus infection, on both samples. 
Additional Western blots carried out at Asahikawa Medi-
cal College (Asahikawa, Japan) using recombinant anti-
gens (RecAgB8/1, more speciﬁ  c for E. granulosus, and 
RecEm18, more speciﬁ  c for E. multilocularis; 7,8) also 
showed strong responses. On the basis of serologic patterns 
obtained with recombinant antigens, with no knowledge of 
the patient’s clinical background, travel history, or images 
of the lesion, E. granulosus infection with many multiple 
cysts, advanced E. multilocularis, or advanced E. vogeli in-
fection was suspected (7,9).
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 12, December 2009  2029 
1These authors contributed equally to this article.
Author afﬁ  liations: Université de Franche-Comté, Besançon, France 
(J. Knapp, F. Grenouillet, J.-M. Bart, L. Millon); Asahikawa Medical 
College, Asahikawa, Hokkaido, Japan (J. Knapp, Y. Sako, S. Itoh, 
M. Nakao, A. Ito); Saint-Louis Hospital, Paris, France (M. Chirica); 
Pasteur Institute of French Guiana, Cayenne, French Guiana (C. 
Simonnet); and World Health Organization Collaborating Center for 
Prevention and Treatment of Human Echinococcosis, Besançon (J. 
Knapp, F. Grenouillet, L. Millon) 
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to the GenBank database by using a highly polymorphic 
DNA target (10). DNA from the liver lesion was extract-
ed by using the High Pure PCR Preparation Kit (Roche, 
Mannheim, Germany). A part of the cox1 mitochondrial 
gene was sequenced by using the E. vogeli–speciﬁ  c primer 
set (cox1_F: 5′-TTAATTTTGCCTGGGTTTGG-3′ and 
cox1_R: 5′-ACGACCCATATGATCCCAAA-3′). A se-
quence of 492 bp was obtained with the ABI 310 sequenc-
er (Applied Biosystems, Foster City, CA, USA) and was 
compared with Echinococcus spp. sequences published in 
the GenBank database (online Appendix Table, available 
from www.cdc.gov/EID/content/15/12/2029-appT.htm). 
The sequences were aligned by using BioEdit 7.0.9.0 (11), 
and sequence identity matrix was generated based on the 
percentage of base pairs in common between species. The 
cox1 sequence was found to be 100% identical to E. vogeli 
species originating from Colombia (GenBank accession 
no. AB208546; 2) and was clearly distinguishable from all 
other Echinococcus species (online Appendix Table).
On the basis of imaging showing numerous multiple 
cysts, serologic examination showing typical patterns for 
both alveolar and cystic echinococcosis, and the life history 
of the patient, the diagnosis of polycystic echinococcosis 
caused by E. vogeli could have been made before surgi-
cal intervention (5,7,9). The immunoblot showing a strong 
antibody response to recombinant AgB suggested a large 
volume of cyst ﬂ  uid. Therefore, the immunoblot showing 
strong responses to both recombinant Em18 and AgB may 
be a typical pattern for advanced E. vogeli infection (data 
not shown). Because few studies using serologic analysis 
on human E. vogeli cases have been published, it would be 
useful to study antibody responses using recombinant an-
tigens with large numbers of such patients and to compare 
the results with patterns observed with alveolar and cystic 
echinococcosis (7,9). 
After surgery, identiﬁ  cation of parasite hooks was car-
ried out. The hooks showed the characteristic shape of E. 
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Figure 1. Computed tomography (A) and magnetic resonance (B) 
images of the liver of a 72-year-old man from French Guiana with 
polycystic echinococcosis affecting the left side of the liver. White 
arrows indicate the multicystic liver lesion. 
Figure 2. Large (A) and small (B) hooks from Echinococcus vogeli 
protoscoleces in the liver lesion of a 72-year-old man from French 
Guiana. Scale bars = 10μm.E. vogeli Infection, French Guiana
vogeli and thus differed from E. granulosus (mean lengths 
of large hooks 25.9–35 μm, and small hooks 22.6–27.8 
μm) and E. oligarthrus (30.5–33.4 μm and 25.4–27.3 μm, 
respectively) (12,13). E. granulosus and E. oligarthrus also 
occur in South America. The presence of hooks indicated 
that the parasite lesion was fertile in our patient, as shown 
in ≈50% of cases (5). Based on mitochondrial DNA analy-
sis, the parasite identiﬁ  cation was conﬁ  rmed as E. vogeli. 
Further molecular studies on the haplotypes of this species 
may give information concerning the genetic diversity and 
circulation of the parasite in South America (14).
Albendazole has been used for medical management 
of alveolar and advanced cystic echinococcosis (3). Several 
instances of its efﬁ  cacy on polycystic echinococcosis have 
been reported, but given the primacy of surgical manage-
ment of these infections, albendazole will probably remain 
an additional treatment (5).
Neotropical echinococcosis cases are rare compared 
with alveolar and cystic echinococcosis (5). This rarity is 
probably because of the sylvatic life cycle of these species. 
However, because domestic dogs have been introduced to 
areas where E. vogeli is present in its natural cycle, the po-
tential for transmission of the parasites from dogs to hu-
mans by close contact exists. The at-risk population mainly 
lives in rural areas and has limited access to medical ser-
vices, which strongly suggests that many infected persons 
cannot receive adequate treatment for this underestimated 
disease.
Conclusions
We report an autochthonous case of E. vogeli infec-
tion documented in French Guiana. Further investigations 
are needed to improve the serologic diagnosis of this in-
fection and to deﬁ  ne its typical serologic pattern compared 
with echinococcosis. Healthcare providers need to be alert 
to the existence of neotropical echinococcosis and should 
consider the possibility of its emergence in Central and 
South America. Although rare, this disease is still lethal in 
untreated cases. 
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